查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1957076

日本医疗植入市场规模、份额、趋势和预测：按产品、材质和地区划分，2026-2034年

Japan Medical Implants Market Size, Share, Trends and Forecast by Product, Material, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2025年，日本医疗植入市场规模达87.369亿美元。 IMARC集团预测，到2034年，该市场规模将达到127.867亿美元，2026年至2034年的复合年增长率（CAGR）为4.32%。人口老化以及心血管疾病和整形外科疾病等慢性病盛行率的上升，推动了该市场的稳定成长。 3D列印技术和先进生物材料等创新技术也提高了植入的客製化程度，并改善了患者的治疗效果。此外，微创手术技术的广泛应用也促进了日本医疗植入市场份额的扩大。

日本医疗植入市场趋势：

人口老化和慢性病增加

日本是世界上老化程度最高的国家之一，65岁以上人口比例显着增加。伴随人口结构的变化，骨关节炎、心血管疾病和骨骼相关疾病在老年族群中日益普遍。这导致寻求人工髋关节和膝关节关节重建、心臟起搏器植入和人工植牙等治疗的患者数量增加。随着老年人口的增长，植入手术的数量也随之增加，从而催生了对高耐磨性、长寿命且体内安全性高的产品的需求。此外，糖尿病和肥胖等问题常常会导致併发症，而其中许多併发症可以透过植入手术来解决。随着日本预期寿命的不断延长和医疗需求的持续增长，对可靠有效的医疗植入解决方案的需求在推动市场扩张方面发挥核心作用。

植入技术进步

技术创新是日本医疗植入市场成长的主要驱动力。 3D列印技术、机器人辅助手术和智慧植入技术的融合正在变革患者照护。这些进步使得植入能够更加个人化，更好地贴合患者的解剖结构，从而改善手术效果并缩短復原时间。此外，新型生物材料的研发正在提升植入的耐用性、生物相容性和抗感染能力。日本强大的研发基础，以及医疗机构、大学和科技公司之间的合作，正在促进快速创新。高效率的法规环境也加速了新医疗设备的核准，推动了先进技术的应用。由于这些改进能够提高患者满意度、降低手术创伤性并从长远角度提升成本效益，因此创新是日本医疗植入市场成长的核心支柱。

政府支持和医疗基础设施

日本政府透过优惠的政策、医疗补贴和创新资金，在支持医疗植入市场方面发挥着至关重要的作用。该国的全民健保体係以及广泛的外科和復健服务，使得更多患者能够接受植入手术。诸如药品和医疗设备管理局（PMDA）等机构简化了新植入的核准流程，同时确保了安全性。此外，政府资助的计画促进了技术研究和产学合作。包括现代化医院和专业外科中心在内的基础设施建设，使得先进的植入手术在全国得以普及。这些措施不仅改善了病患的就医途径和治疗效果，也为国内外企业在日本医疗植入生态系统中投资和发展创造了稳定的环境。

本报告解答的主要问题

  • 日本医疗植入市场迄今的发展如何？预计未来几年将如何发展？
  • 日本医疗植入市场按产品类型分類的市场组成为何？
  • 日本医疗植入市场依材料划分是怎样的？
  • 日本医疗植入市场的区域分布如何？
  • 日本医疗植入市场价值链的不同阶段有哪些？
  • 日本医疗植入市场的主要驱动因素和挑战是什么？
  • 日本医疗植入市场的结构是怎么样的？主要参与者有哪些？
  • 日本医疗植入市场竞争有多激烈？

目录

第一章：序言

第二章：调查范围与调查方法

  • 调查目的
  • 相关利益者
  • 数据来源
  • 市场估值
  • 调查方法

第三章执行摘要

第四章：日本医疗植入市场：简介

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争资讯

第五章：日本医疗植入市场：现状

  • 过去和当前的市场趋势（2020-2025）
  • 市场预测（2026-2034）

第六章：日本医疗植入市场：依产品类型细分

  • 整形外科植入
  • 心血管植入
  • 眼科植入
  • 植入
  • 脸部植入
  • 植入
  • 其他的

第七章：日本医疗植入市场：依材料细分

  • 金属生物材料
  • 聚合物生物材料
  • 天然生物材料
  • 陶瓷生物材料

第八章：日本医疗植入市场：区域细分

  • 关东地区
  • 关西、近畿地区
  • 中部地区
  • 九州和冲绳地区
  • 东北部地区
  • 中国地区
  • 北海道地区
  • 四国地区

第九章：日本医疗植入市场：竞争格局

  • 概述
  • 市场结构
  • 市场公司定位
  • 关键成功策略
  • 竞争对手仪錶板
  • 企业估值象限

第十章：主要企业概况

第十一章：日本医疗植入市场：产业分析

  • 驱动因素、限制因素和机会
  • 波特五力分析
  • 价值链分析

第十二章附录

简介目录
Product Code: SR112026A36512

The Japan medical implants market size reached USD 8,736.9 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 12,786.7 Million by 2034, exhibiting a growth rate (CAGR) of 4.32% during 2026-2034. The market is advancing steadily, propelled by an aging population and increasing prevalence of chronic conditions such as cardiovascular and orthopedic disorders. Innovations like 3D printing and advanced biomaterials are also enhancing implant customization and patient outcomes. The adoption of minimally invasive surgical techniques is further contributing to the expansion of the Japan medical implants market share.

JAPAN MEDICAL IMPLANTS MARKET TRENDS:

Aging Population and Rising Chronic Diseases

One of the oldest populations in the world is found in Japan, with a significant portion aged 65 and above. Due to the shift in demographics, osteoarthritis, cardiovascular disease and conditions affecting bones are more common among seniors. This has led to more people seeking treatments using hip and knee replacements, pacemakers and dental implants. The rise in older people leads to more implant surgeries and also requires products that resist wear, provide long life, and are safe in the body. Moreover, problems like diabetes and obesity lead to complications that are often solved with surgeries using implants. As Japan continues to face rising life expectancy and healthcare needs, the demand for reliable and effective medical implant solutions plays a central role in driving market expansion.

Advancements in Implant Technology

Technological innovation is a key driver of growth in Japan's medical implants market. The integration of 3D printing, robotic-assisted surgery, and smart implant technology is transforming patient care. These advancements allow for more personalized implants that match the patient's anatomy, improving surgical outcomes and recovery times. Additionally, the development of new biomaterials enhances implant durability, biocompatibility, and resistance to infection. Japan's strong R&D infrastructure and collaboration between medical institutions, universities, and tech companies foster rapid innovation. Regulatory support for approving new devices efficiently also accelerates the adoption of cutting-edge technologies. These improvements enhance patient satisfaction and also make procedures less invasive and more cost-effective in the long term, making innovation a core pillar of Japan medical implants market growth.

Government Support and Healthcare Infrastructure

Japan's government plays a crucial role in supporting the medical implants market through favorable regulations, healthcare subsidies, and innovation funding. The country has a universal healthcare system that provides broad access to surgical and rehabilitation services, enabling more patients to afford implant procedures. Agencies such as the Pharmaceuticals and Medical Devices Agency (PMDA) ensure safety while streamlining approval processes for new implants. Additionally, government-funded programs promote technological research and partnerships between academia and industry. Infrastructure developments, including modern hospitals and specialized surgical centers, ensure that advanced implant procedures are widely available across the country. These efforts not only improve patient access and outcomes but also create a stable environment for international and local companies to invest and grow within Japan's medical implants ecosystem.

JAPAN MEDICAL IMPLANTS MARKET SEGMENTATION:

Product Insights:

  • Orthopedic Implants

Hip Orthopedic Device

Joint Reconstruction

Knee Orthopedic Devices

Spine Orthopedic Devices

Others

  • Cardiovascular Implants

Pacing devices

Stents

Structural Cardiac Implants

  • Ophthalmic Implants

Intraocular lens

Glaucoma Implants

  • Dental Implants
  • Facial Implants
  • Breast Implants

Hip Orthopedic Device

Joint Reconstruction

Knee Orthopedic Devices

Spine Orthopedic Devices

Others

Pacing devices

Stents

Structural Cardiac Implants

Intraocular lens

Glaucoma Implants

Material Insights:

  • Metallic Biomaterial
  • Polymers Biomaterial
  • Natural Biomaterial
  • Ceramic Biomaterial

Regional Insights:

  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region

The report has also provided a comprehensive analysis of all the major regional markets, which include the Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How has the Japan medical implants market performed so far and how will it perform in the coming years?
  • What is the breakup of the Japan medical implants market on the basis of product?
  • What is the breakup of the Japan medical implants market on the basis of material?
  • What is the breakup of the Japan medical implants market on the basis of region?
  • What are the various stages in the value chain of the Japan medical implants market?
  • What are the key driving factors and challenges in the Japan medical implants market?
  • What is the structure of the Japan medical implants market and who are the key players?
  • What is the degree of competition in the Japan medical implants market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Medical Implants Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Medical Implants Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Medical Implants Market - Breakup by Product

  • 6.1 Orthopedic Implants
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Segmentation
      • 6.1.3.1 Hip Orthopedic Device
      • 6.1.3.2 Joint Reconstruction
      • 6.1.3.3 Knee Orthopedic Devices
      • 6.1.3.4 Spine Orthopedic Devices
      • 6.1.3.5 Others
    • 6.1.4 Market Forecast (2026-2034)
  • 6.2 Cardiovascular Implants
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Segmentation
      • 6.2.3.1 Pacing devices
      • 6.2.3.2 Stents
      • 6.2.3.3 Structural Cardiac Implants
    • 6.2.4 Market Forecast (2026-2034)
  • 6.3 Ophthalmic Implants
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2020-2025)
    • 6.3.3 Market Segmentation
      • 6.3.3.1 Intraocular lens
      • 6.3.3.2 Glaucoma Implants
    • 6.3.4 Market Forecast (2026-2034)
  • 6.4 Dental Implants
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2020-2025)
    • 6.4.3 Market Forecast (2026-2034)
  • 6.5 Facial Implants
    • 6.5.1 Overview
    • 6.5.2 Historical and Current Market Trends (2020-2025)
    • 6.5.3 Market Forecast (2026-2034)
  • 6.6 Breast Implants
    • 6.6.1 Overview
    • 6.6.2 Historical and Current Market Trends (2020-2025)
    • 6.6.3 Market Forecast (2026-2034)
  • 6.7 Others
    • 6.7.1 Historical and Current Market Trends (2020-2025)
    • 6.7.2 Market Forecast (2026-2034)

7 Japan Medical Implants Market - Breakup by Material

  • 7.1 Metallic Biomaterial
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Polymers Biomaterial
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)
  • 7.3 Natural Biomaterial
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2020-2025)
    • 7.3.3 Market Forecast (2026-2034)
  • 7.4 Ceramic Biomaterial
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2020-2025)
    • 7.4.3 Market Forecast (2026-2034)

8 Japan Medical Implants Market - Breakup by Region

  • 8.1 Kanto Region
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Breakup by Product
    • 8.1.4 Market Breakup by Material
    • 8.1.5 Key Players
    • 8.1.6 Market Forecast (2026-2034)
  • 8.2 Kansai/Kinki Region
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Breakup by Product
    • 8.2.4 Market Breakup by Material
    • 8.2.5 Key Players
    • 8.2.6 Market Forecast (2026-2034)
  • 8.3 Central/ Chubu Region
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2020-2025)
    • 8.3.3 Market Breakup by Product
    • 8.3.4 Market Breakup by Material
    • 8.3.5 Key Players
    • 8.3.6 Market Forecast (2026-2034)
  • 8.4 Kyushu-Okinawa Region
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2020-2025)
    • 8.4.3 Market Breakup by Product
    • 8.4.4 Market Breakup by Material
    • 8.4.5 Key Players
    • 8.4.6 Market Forecast (2026-2034)
  • 8.5 Tohoku Region
    • 8.5.1 Overview
    • 8.5.2 Historical and Current Market Trends (2020-2025)
    • 8.5.3 Market Breakup by Product
    • 8.5.4 Market Breakup by Material
    • 8.5.5 Key Players
    • 8.5.6 Market Forecast (2026-2034)
  • 8.6 Chugoku Region
    • 8.6.1 Overview
    • 8.6.2 Historical and Current Market Trends (2020-2025)
    • 8.6.3 Market Breakup by Product
    • 8.6.4 Market Breakup by Material
    • 8.6.5 Key Players
    • 8.6.6 Market Forecast (2026-2034)
  • 8.7 Hokkaido Region
    • 8.7.1 Overview
    • 8.7.2 Historical and Current Market Trends (2020-2025)
    • 8.7.3 Market Breakup by Product
    • 8.7.4 Market Breakup by Material
    • 8.7.5 Key Players
    • 8.7.6 Market Forecast (2026-2034)
  • 8.8 Shikoku Region
    • 8.8.1 Overview
    • 8.8.2 Historical and Current Market Trends (2020-2025)
    • 8.8.3 Market Breakup by Product
    • 8.8.4 Market Breakup by Material
    • 8.8.5 Key Players
    • 8.8.6 Market Forecast (2026-2034)

9 Japan Medical Implants Market - Competitive Landscape

  • 9.1 Overview
  • 9.2 Market Structure
  • 9.3 Market Player Positioning
  • 9.4 Top Winning Strategies
  • 9.5 Competitive Dashboard
  • 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

  • 10.1 Company A
    • 10.1.1 Business Overview
    • 10.1.2 Products Offered
    • 10.1.3 Business Strategies
    • 10.1.4 SWOT Analysis
    • 10.1.5 Major News and Events
  • 10.2 Company B
    • 10.2.1 Business Overview
    • 10.2.2 Products Offered
    • 10.2.3 Business Strategies
    • 10.2.4 SWOT Analysis
    • 10.2.5 Major News and Events
  • 10.3 Company C
    • 10.3.1 Business Overview
    • 10.3.2 Products Offered
    • 10.3.3 Business Strategies
    • 10.3.4 SWOT Analysis
    • 10.3.5 Major News and Events
  • 10.4 Company D
    • 10.4.1 Business Overview
    • 10.4.2 Products Offered
    • 10.4.3 Business Strategies
    • 10.4.4 SWOT Analysis
    • 10.4.5 Major News and Events
  • 10.5 Company E
    • 10.5.1 Business Overview
    • 10.5.2 Products Offered
    • 10.5.3 Business Strategies
    • 10.5.4 SWOT Analysis
    • 10.5.5 Major News and Events

11 Japan Medical Implants Market - Industry Analysis

  • 11.1 Drivers, Restraints, and Opportunities
    • 11.1.1 Overview
    • 11.1.2 Drivers
    • 11.1.3 Restraints
    • 11.1.4 Opportunities
  • 11.2 Porters Five Forces Analysis
    • 11.2.1 Overview
    • 11.2.2 Bargaining Power of Buyers
    • 11.2.3 Bargaining Power of Suppliers
    • 11.2.4 Degree of Competition
    • 11.2.5 Threat of New Entrants
    • 11.2.6 Threat of Substitutes
  • 11.3 Value Chain Analysis

12 Appendix